Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| AZN.L | +2.24% | +7.83% | +11.77% | +16.76% | +10.46% | +3.26% | +13.06% | +42.03% | +53.65% |
| SCBIHEALT(SSFE) | +11.47% | +2.56% | +6.82% | +8.66% | +11.98% | +22.08% | +15.62% | +25.88% | −2.83% |
| SCBGHCA | +9.95% | +2.75% | +5.09% | +7.14% | +4.37% | +13.81% | +19.12% | +42.69% | +45.56% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes AZN.L: money market or bond funds, or no holdings data yet
| SCBIHEALT(SSFE) | SCBGHCA | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 9.59% | 9.72% |
 ABBVIE | 6.48% | 4.99% |
 AstraZeneca | 5.99% | 3.75% |
 Thermo Fisher | 4.12% | 3.39% |
 argenx | 3.12% | 2.48% |
 Merck & | 6.49% | 2.38% |
| Only in SCBIHEALT(SSFE) | ||
 Gilead Sciences | 5.08% | N/A |
 Vertex Pharmaceuticals | 4.83% | N/A |
 Intuitive Surgical | 4.32% | N/A |
 Jazz Pharmaceuticals | 3.40% | N/A |
| Only in SCBGHCA | ||
 Johnson & Johnson | N/A | 7.87% |
 Unitedhealth Group | N/A | 4.32% |
 Novartis | N/A | 2.76% |
 Roche | N/A | 2.71% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBIHEALT(SSFE) | +11.47% | 17.39% | 0.66 |
| SCBGHCA | +9.95% | 16.81% | 0.59 |
| AZN.L | +2.24% | 29.38% | 0.08 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | AZN.L | SCBIHEALT(SSFE) | SCBGHCA |
|---|---|---|---|
Fund details | |||
| Fund size | N/A | 10.11 million | 954 million |
| Inception date | N/A | 29 Jun 2021 | 2 Sep 2015 |
| Master fund | N/A | BNP Paribas Funds Health Care Innovators | Janus Henderson Global Life Sciences Fund |
| Dividend policy | N/A | Pays | Does not pay |
Risk and currency hedging | |||
| Risk level | N/A | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Almost fully hedged |
| Share hedged | N/A | 82.39% | 100.09% |
Minimum purchase and redemption | |||
| First purchase | N/A | 1 THB | 1 THB |
| Subsequent purchase | N/A | 1 THB | 1 THB |
| Redemption (amount) | N/A | No minimum | 1 THB |
| Redemption (units) | N/A | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | 1 THB |
| Balance (units) | N/A | No minimum | No minimum |
Order cut-off and redemption payment | |||
| Buy before | N/A | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+5 |
